Rossari Biotech's EBIT per Share for the
three
months ended in Mar. 2026 was ₹13.22.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹41.67.
During the past 12 months, the average EBIT per Share Growth Rate of Rossari Biotech was 1.30% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 7.80% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 12.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Rossari Biotech's EBIT per Share or its related term are showing as below:
NSE:ROSSARI'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 7.8 Med: 17.45 Max: 35.5
Current: 7.8
During the past 9 years, the highest 3-Year average EBIT per Share Growth Rate of Rossari Biotech was 35.50% per year. The lowest was 7.80% per year. And the median was 17.45% per year.
NSE:ROSSARI's 3-Year EBIT Growth Rate is ranked better than 63.43% of 1337
companies
in the Chemicals industry
Industry Median: -1.2
vs NSE:ROSSARI: 7.80
Rossari Biotech's EBIT for the
three
months ended in Mar. 2026 was ₹733 Mil.
Rossari Biotech (NSE:ROSSARI) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Rossari Biotech EBIT per Share Related Terms
Rossari Biotech EBIT per Share Historical Data
* Premium members only.
The historical data trend for Rossari Biotech's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹41.67
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rossari Biotech (NSE:ROSSARI) has a EBIT per Share of ₹41.67 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Rossari Biotech and its competitors. According to the industry distribution chart, Rossari Biotech ranks #489 out of 1337 companies in the Chemicals industry, placing it in the top 36.6%.
Is Rossari Biotech's EBIT per Share too high?
Rossari Biotech's current EBIT per Share is ₹41.67. Based on the distribution chart, Rossari Biotech ranks #489 out of 1337 companies in the Chemicals industry, which is above the industry midpoint. Overall, Rossari Biotech has a GF Score™ of 84/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Rossari Biotech's EBIT per Share compare to LIN and SHW?
According to the Chemicals industry distribution chart, Rossari Biotech ranks #489 out of 1337 companies for EBIT per Share. This puts Rossari Biotech in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Chemicals company?
A good EBIT per Share depends on the Chemicals industry context. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Rossari Biotech and its competitors. Rossari Biotech's current EBIT per Share is ₹41.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rossari Biotech stock overvalued right now?
Based on GuruFocus' analysis, Rossari Biotech (NSE:ROSSARI) is currently considered Possible Value Trap. The stock's GF Value™ is ₹1,000.03, compared to a current price of ₹524.20 — trading 47.6% below its estimated fair value. The current EBIT per Share is ₹41.67. Rossari Biotech's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Rossari Biotech (NSE:ROSSARI), the current EBIT per Share is ₹41.67 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rossari Biotech (NSE:ROSSARI) Overvalued in 2026?
Based on GuruFocus' analysis, Rossari Biotech stock appears to be undervalued.
The current stock price of ₹524.20 is trading 47.6% below its estimated GF Value™ of ₹1,000.03.
GuruFocus considers Rossari Biotech to be Possible Value Trap.
Key valuation signals for NSE:ROSSARI:
EBIT per Share: ₹41.67
GF Value™: ₹1,000.03 vs. price of ₹524.20 (47.6% below fair value)
No single metric tells the full story. See the NSE:ROSSARI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rossari Biotech Ltd is a specialty chemical manufacturing company. It provides customized solutions to specific industrial and production requirements of its customers in the FMCG, apparel, poultry, and animal feed industries through its product portfolio comprising home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its business is organized into three categories: home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its products include soaps and detergents, paints, inks and coatings, ceramics and tiles, water treatment chemicals, pulp and paper, and cleaning chemical formulations, among others. The company generates the majority revenue from India.
84GF Score
Get the complete analysis for NSE:ROSSARI
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ROSSARI has been successfully added to your 
